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Oct4MicroRNAs (miRNAs) have emerged as critical regulators of gene expression. These small, non-coding RNAs
are believed to regulate more than a third of all protein coding genes, and they have been implicated in the
control of virtually all biological processes, including the biology of stem cells. The essential roles of miRNAs
in the control of pluripotent stem cells were clearly established by the ﬁnding that embryonic stem (ES) cells
lacking proteins required for miRNA biogenesis exhibit defects in proliferation and differentiation.
Subsequently, the function of numerous miRNAs has been shown to control the fate of ES cells and to
directly inﬂuence critical gene regulatory networks controlled by pluripotency factors Sox2, Oct4, and Nanog.
Moreover, a growing list of tissue-speciﬁc miRNAs, which are silenced or not processed fully in ES cells, has
been found to promote differentiation upon their expression and proper processing. The importance of
miRNAs for ES cells is further indicated by the exciting discovery that speciﬁc miRNA mimics or miRNA
inhibitors promote the reprogramming of somatic cells into induced pluripotent stem (iPS) cells. Although
some progress has been made during the past two years in our understanding of the contribution of speciﬁc
miRNAs during reprogramming, further progress is needed since it is highly likely that miRNAs play even
wider roles in the generation of iPS cells than currently appreciated. This review examines recent
developments related to the roles of miRNAs in the biology of pluripotent stem cells. In addition, we posit
that more than a dozen additional miRNAs are excellent candidates for inﬂuencing the generation of iPS cells
as well as for providing new insights into the process of reprogramming.in Cancer and Allied Diseases,
ka Medical Center, Omaha, NE
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The seminal ﬁnding that lin-4, and later let-7, are developmental
regulators of Caenorhabditis elegans sparked the exciting discovery
that a class of small RNAs plays critical roles in the regulation of gene
expression (Lee et al., 1993; Reinhart et al., 2000). Subsequently,
homologs of let-7 were identiﬁed in higher organisms, including
mammals (Pasquinelli et al., 2000) and, soon thereafter, it was
recognized that these small RNAs belong to a large family of non-
coding RNAs known as microRNAs (miRNAs) (Lagos-Quintana et al.,
2001; Lau et al., 2001; Lee and Ambros, 2001). miRNAs have emerged
as key regulators of gene silencing that act by targeting speciﬁc
mRNAs for degradation or by suppressing their translation. Remark-
ably, miRNAs are believed to regulate more than a third of all protein
coding genes, and they have been shown to directly inﬂuence virtually
all biological processes, including stem cell self-renewal and lineage
speciﬁcation during development, as well as diseases, such as cancer(Kanellopoulou et al., 2005; Murchison et al., 2005; Wang et al., 2007;
Kato and Slack, 2008; Liu et al., 2008; Stefani and Slack, 2008; Wang
et al., 2008b; Cordes and Srivastava, 2009; Friedman and Jones, 2009).
In this review, we discuss the varied roles played by miRNA in the
maintenance of embryonic stem (ES) cell self-renewal and pluripo-
tency. We also discuss several recent studies that have begun to probe
the roles of miRNAs during the reprogramming of somatic cells into
induced pluripotent stem (iPS) cells. Finally, we discuss whymore than
a dozen additional miRNAs are likely to inﬂuence the process of
reprogramming. Not discussed in this review are studies dealing with
miRNAs in adult stem cells. Readers interested in this topic are referred
to several excellent reviews (Zhao and Srivastava, 2007; Lakshmipathy
and Hart, 2008; Gangaraju and Lin, 2009; Li and Jin, 2010).
Biogenesis of miRNAs
miRNAs provide an additional level of gene regulation by
functioning at the post-transcriptional level. Location ofmiRNA coding
sequences can be either intragenic or intergenic, andmiRNAs aremost
often transcribed by RNA polymerase II (Bartel., 2004; Rodriguez et al.,
2004). Generation of mature miRNAs involves both nuclear and
cytoplasmic steps (Fig. 1). Once transcribed, primary-miRNA (pri-
Fig. 1. Schematic representation of the miRNA biogenesis. miRNA biogenesis involves both nuclear and cytoplasmic steps. Following transcription, pri-miRNAs are processed into
pre-miRNAs by a microprocessor complex containing Drosha and DGCR8. Pre-miRNAs are exported from the nucleus into the cytoplasm by Exportin 5–RanGTP. In the cytoplasm,
pre-miRNAs are processed into mature miRNA duplex by Dicer, which functions in concert with TRBP. One of the strands from the mature miRNA duplex, the guide strand, is loaded
into the Argonaute–RISC complex. The guide strand then directs the RISC complex to mRNA target sequences to mediate gene silencing.
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∼70-nucleotide precursor-miRNAs (pre-miRNAs) by amicroprocessor
complex, which contains RNase III enzyme Drosha and RNA binding
protein DiGeorge syndrome Critical Region gene 8 (DGCR8) (Lee et al.,
2002; Lee et al., 2003; Zeng and Cullen, 2003; Kim., 2005). Pre-miRNAs
are transported into the cytoplasm by Exportin 5, followed by Dicer-
mediated processing into ∼22-nucleotide mature miRNA duplexes
(Lee et al., 2003; Yi et al., 2003; Lund et al., 2004). Like Drosha, Dicer
functions in concert with RNA binding protein Transactivating Region
Binding Protein (TRBP) (Chendrimada et al., 2005; Haase et al., 2005).
One of the miRNA duplex strands serves as a guide strand and is
incorporated into the Argonaute-containing RISC complex, while the
other strand is released and degraded (Maniataki and Mourelatos,
2005). The eight-nucleotide seed sequence in the 5′ terminus of themiRNA guide strand is critical for target recognition, and the guide
strand directs the RISC complex to targetmRNA sequences (Brennecke
et al., 2005; Lewis et al., 2005). Target recognition by miRNA is often
mediated by imperfect base pairing with a region that lies in the 3′
untranslated region (UTR) of mRNA. Imperfect base pairing with their
targets enables miRNAs to target multiple genes simultaneously.
Recent studies have demonstrated thatmiRNAs can also target regions
outside of the 3′ UTR, such as regions in 5′ UTR and the amino acid
coding sequence of mRNA (Lytle et al., 2007; Tay et al., 2008a).
Roles of miRNAs in the establishment of the ES cell phenotype
ES cells have a unique ability to replicate indeﬁnitely (self-
renewal), yet they are capable of forming all cell types of the body
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counterparts, iPS cells, offer immense potential for the ﬁeld of
regenerative medicine. However, before ES cells and iPS cells are
used clinically, a thorough understanding of the mechanisms that
control pluripotent stem cell identity would be extremely valuable.
Recent work has demonstrated that miRNAs play key roles in
controlling the fate of ES cells. Contribution of miRNA pathways to
ES cell identity has been studied using Dicer null and DGCR8 null ES
cells, which lack all mature miRNAs (Kanellopoulou et al., 2005;
Murchison et al., 2005; Wang et al., 2007). Dicer is necessary for
maturation of both miRNAs and small interfering RNAs, whereas
DGCR8 is not required for small interfering RNA processing (Denli et
al., 2004; Gregory et al., 2004; Han et al., 2004; Landthaler et al., 2004;
Wang et al., 2007). Dicer null ES cells exhibit slow proliferation rates
and defective differentiation (Kanellopoulou et al., 2005;Murchison et
al., 2005). When these cells are induced to differentiate in embryoid
bodies, Oct4 expression is only partially decreased, and endodermal
and mesodermal markers, which are typically expressed by differen-
tiated ES cells, are not detectable (Kanellopoulou et al., 2005). DGCR8
null ES cells also exhibit defective differentiation (Wang et al., 2007).
When these cellswere subjected to conditions that normally induce ES
cell differentiation, they exhibited abnormal activation of multiple
markers of differentiation, coupled with the inability to silence
expression of pluripotency markers. DGCR8 null ES cells accumulate
in the G1 phase of the cell cycle, indicating that DGCR8 is necessary for
normal ES cell proliferation and cell cycle progression (Wang et al.,
2007). Together, these studies demonstrated the requirement of
mature miRNAs for the maintenance of ES cell self-renewal and
pluripotency. Additionally, several independent studies have identi-
ﬁed distinct miRNAs expressed in ES cells and their differentiated
counterparts, reinforcing the role of ES cell-speciﬁc miRNAs in
regulating ES cell identity (Houbaviy et al., 2003; Bar et al., 2008;
Laurent et al., 2008).
Convergence of miRNAs and a key ES cell gene regulatory network
Recently, signiﬁcant progress has been made towards understand-
ing the contribution of speciﬁc miRNAs in establishing the ES cell
phenotype (summarized in Fig. 2). It is becoming evident thatmiRNAs
are an integral part of the gene networks regulated by pluripotency
factors Sox2, Oct4, and Nanog. Genome-wide binding assays of Sox2,
Oct4, and Nanog demonstrated that these transcription factors co-
occupy promoters of the majority of miRNAs that are preferentially
expressed in mouse ES cells, including the miR-290 cluster and miR-
302 cluster miRNAs (Marson et al., 2008). Moreover, these transcrip-
tion factors not only bind to the promoters of the miR-290 cluster and
the miR-302 cluster, but they have also been shown to regulate the
expression of these miRNAs (Barroso-delJesus et al., 2008; Card et al.,
2008; Marson et al., 2008).
It is becoming evident that the trio of Sox2, Oct4, and Nanog
utilizes miRNAs to ﬁne tune the expression of their target genes in ES
cells. This is exempliﬁed by the involvement of Sox2, Oct4, and Nanog
in incoherent and coherent feed-forward regulatory networks, by
activating expression of speciﬁc miRNAs, to modulate the levels of
proteins, such as Lefty1 and DNAmethyltransferases 3a and 3b (Dnmt
3a and Dnmt 3b), in ES cells (Marson et al., 2008). Lefty1 participates
in pluripotency regulating transcription networks (Nakatake et al.,
2006), whereas Dnmt 3a and Dnmt 3b are necessary for proper
differentiation of ES cells when they are subjected to appropriate
differentiation cues (Benetti et al., 2008; Sinkkonen et al., 2008).
Recently, two independent studies have investigated the mechanism
responsible for the inability of Dicer null ES cells to silence the self-
renewal program when subjected to conditions that normally
promote differentiation. These studies determined that the miR-290
cluster of miRNAs is required for expression of de novo DNA
methyltransferases in ES cells, and that differentiation defectsobserved in Dicer null ES cells are due, at least in part, to incomplete
and reversible silencing of Oct4 expression, resulting from improper
promoter methylation (Benetti et al., 2008; Sinkkonen et al., 2008).
In addition to the association of Sox2, Oct4, and Nanog with
promoters of miRNAs that are preferentially expressed in ES cells,
Sox2, Oct4, and Nanog also associate with the promoters of silenced
tissue-speciﬁc miRNAs (Marson et al., 2008). It has been suggested
that binding of Sox2, Oct4, and Nanog to these tissue-speciﬁc miRNAs
primes them for expression upon differentiation of ES cells; however,
they are kept silent in ES cells due to the association of these miRNA
genes with inhibitory polycomb repressor proteins (Marson et al.,
2008). In this regard, several tissue-speciﬁc miRNAs are involved in
regulating the expression of critical pluripotency factors, and they
induce differentiation when expressed in ES cells. For example, miR-
296, miR-470, and miR-134, whose expression is upregulated upon
retinoic acid induced differentiation of mouse ES cells, inhibit the
expression of Sox2, Oct4, and Nanog in various combinations (Tay
et al., 2008a,b). In a related study, miR-145 has been shown to repress
pluripotency in human ES cells by downregulating the expression of
Sox2, Oct4, and Klf4 (Xu et al., 2009b). These ﬁndings demonstrate
that miRNAs are an integral part of the core ES cell transcriptional
regulatory network and play important roles in regulating ES cell fate.
Role of miRNAs in ES cell-speciﬁc cell cycle structure
As discussed earlier, DGCR8 null mouse ES cells exhibit cell cycle
defects. To extend these ﬁndings, Wang et al. screened a library of 266
mouse miRNAs for their ability to rescue the cell cycle defects of
DGCR8 null ES cells (Wang et al., 2008b). They determined that a
subset of miRNAs, referred to as ES cell-speciﬁc cell cycle-regulating
miRNAs (ESCC miRNAs) (miR-291a-3p, miR-291b-3p, miR-294, miR-
295, and miR-302), can rescue the ES cell cycle defect. This occurs, at
least in part, by promoting the G1-S transition. These workers also
demonstrated that ESCC miRNAs exert their effect by suppressing the
expression of multiple cyclin E-Cdk2 inhibitors, such as p21, Rbl2, and
Lats2 (Wang et al., 2008b).
To fully understand the roles played by miRNAs in ES cells, it is
important to stress that mouse and human ES cells represent different
stages of mammalian development (Brons et al., 2007; Tesar et al.,
2007). Consequently, it is likely that there are differences in the
mechanisms that control the self-renewal of mouse and human ES
cells. For instance, of the miRNAs belonging to the miR-290 and miR-
302 clusters, miR-302 cluster miRNAs are expressed in both human
and mouse ES cells; whereas, miR-290 cluster is only expressed in
mouse ES cells (Kim et al., 2009c). Furthermore, work with several
miRNAs has only been conducted in human ES cells. For example,
miR-520 cluster miRNAs, whose seed sequence is similar to miR-302
cluster miRNAs, have been shown to regulate important cellular
functions in human ES cells, including cell proliferation and chromatin
structure (Ren et al., 2009). Another miRNA whose function has only
been studied in human ES cells is miR-92b, which promotes the G1-S
transition by repressing the Cdk inhibitor p57 (Sengupta et al., 2009).
Interestingly, genome-wide transcription factor binding assays have
demonstrated that pluripotency factors Sox2 and Oct4 associate with
the promoter of miR-92b in mouse ES cells, suggesting direct
regulation of miR-92b expression by Sox2 and Oct4 (Marson et al.,
2008), and also likely involvement of miR-92b in establishing the
mouse ES cell phenotype.
Opposing roles of ESCC and let-7 miRNAs in the control of ES
cell fate
ESCC and let-7 family miRNAs have begun to emerge as important
regulators of ES cell self-renewal, pluripotency, and differentiation
(Melton et al., 2010). ESCC and let-7 miRNAs represent major miRNAs
expressed in ES cells and somatic cells, respectively (Marson et al.,
Fig. 2. Regulatory networks of miRNAs and proteins involved in control of ES cell self-renewal and differentiation. Black arrow: direct binding and/or activation of miRNA/protein
expression. Black dashed arrow: indirect activation of miRNA/protein expression. Red lines with a vertical stub: direct inhibition of miRNA/protein expression or evidence for direct
inhibition as suggested by binding of the protein to the promoter region. Blue colored ovals (proteins/protein coding genes) and rectangles (miRNAs/miRNA coding genes):
expressed only in ES cells/expressed abundantly in ES cells compared to differentiated cells. Gold colored ovals (proteins/protein coding genes) and rectangles (miRNAs/miRNA
coding genes): expressed only in differentiated cells/expressed abundantly in differentiated cells compared to ES cells. Sox2, Oct4, and Nanog, in addition to regulating the
expression of numerous proteins, regulate the expression of several miRNAs in ES cells, including the miR-290 cluster and miR-302 cluster. Conversely, several tissue-speciﬁc
miRNAs such as miR-296, miR-134, miR-470, and miR-145 inhibit the expression of Sox2, Oct4, and Nanog in ES cells. ESCC miRNAs, which include select miRNAs from the miR-290
cluster and the miR-302 cluster, and let-7 miRNAs have emerged as major regulators of ES cell fate, and exhibit opposing effects on ES cell self-renewal, pluripotency, and
differentiation. ESCC miRNAs belonging to the miR-290 cluster are responsible for ensuring proper ES cell proliferation, as well as proper ES cell differentiation when subjected to
appropriate differentiation cues. let-7 family miRNAs are involved in a negative feedback regulatory loop with Lin28 and c-Myc, both of which have important functions in ES cells
and iPS cells. Lin28, apart from preventing the generation of mature let-7, inhibits the processing of miR-107, miR-143, and miR-200c in ES cells. Furthermore, Lin28 facilitates the
translation of Oct4 in ES cells. c-Myc is involved in a positive feedback regulatory loop with members of the ESCC miRNAs. Additionally, c-Myc induces the expression of miR-141,
miR-200, andmiR-429, which attenuatemouse ES cell differentiation upon LIF withdrawal. c-Myc has also been shown to activate the transcription of themiR-17-92 cluster in tumor
cells. Note: data were compiled from studies involving mouse and human cells.
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promoter is bound by Sox2, Oct4, and Nanog (Marson et al., 2008). In
accordance with this ﬁnding, pri-let-7 transcripts are present at high
levels in ES cells and depletion of Oct4 decreases the levels of pri-let-7
transcripts (Marson et al., 2008). However, processing of pri-let-7 into
mature let-7 is prevented by RNA binding protein Lin28. Lin28 inhibits
both Drosha-mediated (Newman et al., 2008; Viswanathan et al.,
2008) and Dicer-mediated (Heo et al., 2008; Rybak et al., 2008)
processing of pri-let-7 into mature let-7. Mature let-7, in turn, inhibits
the expression of Lin28 (Rybak et al., 2008). Thus, the negative
feedback loop between Lin28 and let-7 has a major inﬂuence over ES
cell fate. Lin28, apart from its role in preventing the generation of
mature let-7, is necessary for proper ES cell proliferation, and also for
efﬁcient translation of Oct4 (Xu et al., 2009a; Qiu et al., 2010).
c-Myc, which is required for maintenance of ES cell self-renewal
(Cartwright et al., 2005), is also involved in a negative feedback
regulatory loop with let-7. c-Myc, through an indirect mechanism
involving transcriptional activation of Lin28, inhibits the biogenesis of
mature let-7 (Chang et al., 2009). Additionally, in lymphoma cells
where expression of c-Myc leads to downregulation of let-7
expression, c-Myc has been shown to bind let-7 promoter, which
suggest that c-Myc directly inhibits let-7 expression (Chang et al.,
2008). Mature let-7, in turn, directly inhibits the expression of c-Myc
(Kumar et al., 2007; Melton et al., 2010). Using DGCR8 null ES cells,
described above, Melton et al. demonstrated that ESCC and let-7
miRNAs play opposing roles in regulating the ES cell phenotype(Melton et al., 2010). Speciﬁcally, they demonstrated that introduc-
tion of ESCC miRNAs into DGCR8 null ES cells rescued the cell cycle
defect, whereas introduction of let-7 miRNAs induced DGCR8 null ES
cells to differentiate.
The effects of let-7 in ES cells can be explained by its inhibitory
effect on the expression of Lin28, c-Myc, Sall4 and downstream target
genes of pluripotency factors, in particular Sox2, Oct4, and Nanog
(Melton et al., 2010). Additionally, let-7 also represses positive
regulators of cell cycle, such as CDK6, CDC25A, and Cyclin D, in
human cancer cells (Johnson et al., 2007). Introduction of let-7 into
wild-type ES cells failed to induce ES cells to differentiate, which
suggests that ESCC miRNAs antagonize the effects of let-7 in ES cells
(Melton et al., 2010). The importance of ESCCmiRNAs in regulating ES
cell fate is further reinforced by the presence of a positive feedback
loop between ESCC miRNAs and Myc. In this regard, ChIP-seq data
have shown that c-Myc and n-Myc bind to the promoter of the miR-
290 cluster, which expresses several ESCC miRNAs, suggesting direct
activation of expression of these miRNAs by Myc (Chen et al., 2008).
c-Myc has also been shown to induce, by an indirect mechanism, the
expressionof themiR-302 cluster,which codes for an ESCCmiRNA (Lin
et al., 2009). Moreover, the ESCC miRNA, miR-294, has been shown to
indirectly activate the expression of c-Myc (Melton et al., 2010).
Recently, c-Myc has been shown to bind to promoter regions of
miR-141, miR-200, and miR-429 and to induce their expression in
mouse ES cells (Lin et al., 2009). Introduction of these c-Myc induced
miRNAs into ES cells attenuated the differentiation of these cells in
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expression is elevated in many cancers, are also enriched in ES cells,
and have similar seed sequences to those of ESCC miRNAs (Laurent
et al., 2008; Marson et al., 2008; Mendell., 2008; Wang et al., 2008b;
Judson et al., 2009). Additionally, c-Myc has been shown to induce the
expression of the miR-17-92 cluster in tumor cells (O'Donnell et al.,
2005). However, the function of the miR-17-92 cluster in ES cells has
not been investigated. The fact that miRNAs from the miR-17-92
cluster have seed sequences similar to those of ESCCmiRNAs, and that
c-Myc induces expression of both miR-17-92 and ESCC miRNAs,
highlights the impact of c-Myc-regulated miRNAs on the self-renewal
of stem cells (He et al., 2005; O'Donnell et al., 2005; Chen et al., 2008).
Regulatory mechanisms involved in establishing the ES
cell-speciﬁc miRNA proﬁle
Although it is clear that miRNAs play critical roles in regulating the
self-renewal and pluripotency of ES cells, much less is known about
the molecular mechanisms that regulate miRNA expression in
pluripotent stem cells. This will necessitate systematic identiﬁcation
and study of both functional core promoter/enhancer elements, and
speciﬁc cis-regulatory elements involved in the regulation of miRNA
expression in ES cells and differentiated cells. A recent study involving
large scale identiﬁcation of miRNA promoters in both human and
mouse cells is an excellent starting point for characterizing individual
miRNA promoters (Marson et al., 2008). Recently, themiR-302 cluster
promoter has been characterized and functionally validated in human
ES cells (Barroso-delJesus et al., 2008; Card et al., 2008). Speciﬁcally, it
has been demonstrated that Sox2 and Oct4 bind the miR-302
promoter and are essential for expression of miR-302 miRNAs in
human ES cells (Card et al., 2008). Similar studies are warranted for
miRNAs, such as themiR-290 cluster, miR-92b, miR-145, miR-134 and
the let-7 cluster, that are known to play important functions in ES cell
self-renewal and differentiation.
Biogenesis of miRNAs, which interfere with ES cell self-renewal
and pluripotency, appears to be tightly regulated at multiple levels in
ES cells. This is exempliﬁed for let-7 miRNAs, whose biogenesis is
controlled at both transcriptional and post-transcriptional levels. As
noted above, c-Myc has been shown to transcriptionally repress let-7
expression in lymphoma cells (Chang et al., 2008), whereas Lin28
prevents processing of pri-let-7 to mature let-7 in ES cells (Heo et al.,
2008; Newman et al., 2008; Rybak et al., 2008; Viswanathan et al.,
2008). Additionally, mouse Lin41 has been shown to suppress let-7
activity, at least in part, by antagonizing Argonaute 2 (Rybak et al.,
2009). Considering the importance of the control of miRNA biogen-
esis, identiﬁcation of proteins that regulate biogenesis of other
lineage-speciﬁc miRNAs, such as miR-134, miR-145, miR-296, in ES
cells is expected to provide greater insight into ES cell biology.
Additionally, a recent study demonstrated that the inhibitory effect of
Lin28 on miRNA processing is not limited to let-7. Processing of
several other miRNAs, including miR-107, miR-143, and miR-200c, is
also inhibited by Lin28 (Heo et al., 2009). In accordance with this
ﬁnding, miR-107, miR-143, and miR-200c are more abundantly
expressed in differentiated cells compared to undifferentiated cells
(Heo et al., 2009). Therefore, additional studies to investigate the
effects of these miRNAs on the fate of ES cells are warranted.
Roles of miRNAs in the reprogramming of somatic cells into
iPS cells
Only four years ago, it was discovered that somatic cells could be
reprogrammed into iPS cells (Takahashi and Yamanaka, 2006). This
brought about a true paradigm shift in the ﬁeld of stem cell biology.
Over the past four years, the original combination of reprogramming
factors [Sox2, Oct4, Klf4, and c-Myc (SOKM)] has been used to
generate iPS cells from a wide-range of cell types (Maherali andHochedlinger, 2008; Cox and Rizzino, 2010). Other combinations,
such as Sox2, Oct4, Lin28 and Nanog, have also been used to generate
iPS cells (Yu et al., 2007). However, relatively little is known about the
roles played bymiRNAs in the reprogramming of somatic cells into iPS
cells. The known effects of miRNAs during reprogramming and several
examples of miRNAs with potential roles in modulating reprogram-
ming are summarized in Fig. 3.
Expression of ES cell-speciﬁc miRNAs promotes reprogramming
As discussed earlier, transient transfection of ESCC miRNAs into
DGCR8 knockout mouse ES cells rescued their proliferation defect
(Wang et al., 2008b). Interestingly, Judson et al. investigated the
effects of ESCC miRNAs on reprogramming of somatic cells into iPS
cells (Judson et al., 2009). For this purpose, mouse embryonic
ﬁbroblasts were infected with retroviruses that express Sox2, Oct4,
and Klf4, and miRNA mimics were introduced into the cells by
transient transfection. They determined that ESCC miRNAs increase
the generation of mouse iPS cells induced by the combination of Sox2,
Oct4, and Klf4. Among different ESCC miRNAs, miR-294 exhibited the
greatest effect on reprogramming and increased efﬁciency of iPS cell
generation from 0.01–0.05% to 0.4–0.7%. Additionally, miR-294
increased the kinetics of Sox2, Oct4, and Klf4 mediated reprogram-
ming. However, when miR-294 was introduced with Sox2, Oct4, Klf4,
and c-Myc, it had no effect on reprogramming. Therefore, ESCC
miRNAs appear to promote Sox2, Oct4, and Klf4 mediated repro-
gramming by substituting for c-Myc. Importantly, iPS cells generated
without c-Myc are likely to be safer for future use in cell-based clinical
therapies. As discussed below, miRNAs from the miR-302 cluster have
also been shown to promote reprogramming.
Inhibition of tissue-speciﬁc miRNAs promotes the formation of
iPS cells
The pro-differentiation effect of let-7 on ES cells prompted Melton
et al. to test the effect of inhibiting the activity of let-7 miRNA on the
reprogramming of somatic cells into iPS cells (Marson et al., 2008;
Rybak et al., 2008; Melton et al., 2010). For this purpose, they
introduced let-7 antisense inhibitor into mouse embryonic ﬁbroblasts
by transient transfection and studied its effects on reprogramming
mediated by Sox2, Oct4, and Klf4, in the presence or absence of c-Myc.
They determined that inhibition of let-7 activity increased Sox2, Oct4,
and Klf4 mediated reprogramming 4.3 fold, whereas Sox2, Oct4, Klf4,
and c-Myc-mediated reprogramming increased only 1.75 fold. These
data argue that increased reprogramming in response to let-7
inhibition is mediated by let-7 target genes, such as c-Myc and
Lin28 (Fig. 2). Interestingly, recent studies have shown that Lin28 is
also repressed by miR-125, which is abundantly expressed in
differentiated cells (Wu and Belasco, 2005; Wilson et al., 2009). This
raises the possibility that inhibiting the activity of both miR-125 and
let-7 miRNAs may result in additional beneﬁcial effects during
reprogramming, due to robust activation of Lin28 expression.
However, elevating Lin28 levels beyond a critical level could have
deleterious effects (Darr and Benvenisty, 2009). Collectively, these
results illustrate the important roles played by miRNAs in reprogram-
ming somatic cells into iPS cells.
Mechanisms for modulating the activities and levels of miRNAs
Multiple methods are available to modulate the activities and
levels of miRNAs. Anti-miRNA oligonucleotides, known as antagomirs,
are routinely used to inhibit miRNA activity (Liu et al., 2008).
Antagomirs bind to mature miRNAs, mediated by Watson–Crick
base pairing, and interfere with their target recognition. The afﬁnity,
stability, safety and delivery of antagomirs have been improved
through chemical modiﬁcations. Four chemical modiﬁcations are
commonly used: replacement of the 2′-OH in the ribose moiety with
2′-O-methyl or 2′-O-methoxyethyl, addition of an extra methylene
bridge to the ribose moiety, and replacement of a non-bridging
oxygen with a sulfur atom in the phosphate backbone (Wahlestedt
et al., 2000; Meister et al., 2004; Davis et al., 2006; Orom et al., 2006;
Liu et al., 2008). Antagomirs are delivered to cells by transient
transfection. Therefore, achieving efﬁcient delivery and stable
expression of these oligonucleotides is not possible. This short-
coming of antagomirs can be overcome by using viral vectors that
code for miRNA sponges, which can provide efﬁcient delivery and
stable expression of anti-miRNAs (Gentner et al., 2009). miRNA
sponges are RNAmolecules that containmultiple miRNA binding sites
(Ebert et al., 2007), and function by sequestering corresponding
miRNAs. miRNA sponges often inhibit the activity of closely related
miRNAs within the same family (Ebert et al., 2007). In addition to
inhibiting miRNA activity by various methods, one can exogenously
express miRNAs by transient transfection of either miRNA mimics or
pre-miRNAs (Tay et al., 2008a; Judson et al., 2009; Sengupta et al.,
2009; Xu et al., 2009b; Melton et al., 2010). Alternatively, exogenous
miRNA expression can be achieved by viral vector-mediated delivery
of pre-miRNA molecules, which provide both efﬁcient delivery and
stable expression of miRNAs (Lin et al., 2008; Xu et al., 2009b).
Recent studies investigating the roles of miRNAs during repro-
gramming employed transient transfection of cells with miRNA
mimics and miRNA inhibitors (Judson et al., 2009; Melton et al.,
2010). It is possible that longer expression of miRNA mimics and
miRNA inhibitors, for example by using viral vectors, may be
necessary to maximize their effects on reprogramming. However,
stable expression of miRNA mimics and miRNA inhibitors that are
helpful during somatic cell reprogramming may interfere with
subsequent lineage-speciﬁc differentiation of the iPS cells. This
problem can be circumvented by using drug-inducible viral vectors.
Moving forward, it would also be desirable to employ methods, such
as adenoviral vectors (Stadtfeld et al., 2008) or non-integrating
episomal vectors (Yu et al., 2009), that deliver miRNA mimics and
miRNA inhibitors without directly altering chromosomal integrity.
Do miRNAs mediate the effects of p53 on reprogramming?
Considering the burgeoning role of miRNAs in regulating ES cell
self-renewal and differentiation, it is conceivable that miRNAs have
much wider and more important roles in reprogramming than is
currently recognized. Recent studies have shown that p53 poses a
barrier to reprogramming, and deletion of p53 signiﬁcantly increases
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2009; Kawamura et al., 2009; Li et al., 2009; Marion et al., 2009).
Moreover, the effects of p53 on reprogramming appear to be
mediated, at least in part, by p21. Accordingly, knock-down of p21
in cells containing wild-type p53 also increases the efﬁciency of
generating iPS cells (Kawamura et al., 2009; Li et al., 2009). However,
inhibition of the p53 pathway results in iPS cell populations contain-
ing a high percentage of cells with DNA damage (Marion et al., 2009).
To overcome the p53-mediated barrier to reprogramming without
compromising the genomic integrity of iPS cells, it is necessary to
understand the mechanisms by which p53 antagonizes reprogram-
ming. A probable role for miRNAs in the p53-mediated barrier to
reprogramming is suggested by the ﬁnding that p53 enhances the
processing and maturation of several miRNAs in human ﬁbroblasts,
including miR-145 (Suzuki et al., 2009). Additionally, p53 has been
shown to bind to the miR-145 promoter and activate its expression
(Sachdeva et al., 2009).
As mentioned earlier, miR-145 induces ES cell differentiation by
inhibiting the expression of key pluripotency/reprogramming factors,
such as Sox2, Oct4, Klf4, and c-Myc (Sachdeva et al., 2009; Xu et al.,
2009b). Hence, it is reasonable to speculate that the p53-mediated
barrier to reprogramming may be due, at least in part, to miR-145. If
this is the case, inhibiting the activity of miR-145 will promote the
reprogramming of human somatic cells into iPS cells by enabling the
early activation of endogenous reprogramming factors. Furthermore,
p53 positively regulates the expression of several miRNAs, in addition
to miR-145 (Suzuki et al., 2009). Therefore, it is possible that the
effects of p53 on reprogramming are mediated through multiple
miRNAs. Further study into the possible roles of p53-regulated
miRNAs may identify still other roles for these non-coding RNAs.
Possible role for miRNAs in promoting epigenetic modiﬁcations
that favor reprogramming
During generation of iPS cells a signiﬁcant portion of the cells are
trapped in partially reprogrammed states characterized by incom-
plete epigenetic remodeling involving persistent DNA hypermethyla-
tion at the promoters of pluripotency-associated genes (Mikkelsen
et al., 2008). One way to improve reprogramming efﬁciency could be
to coax partially reprogrammed cells to undergo complete repro-
gramming. In support of this argument, inhibition or knock-down of
DNA methyltransferase enhanced iPS cell generation by inducing
promoter demethylation of pluripotency-associated genes (Mikkel-
sen et al., 2008). Additionally, Dnmt inhibitors are also used to
generate iPS cells with only two factors (Oct4 and Klf4) or three
factors (Sox2, Oct4, and Klf4) (Huangfu et al., 2008; Shi et al., 2008).
Recently, miR-29b has been shown to induce global DNA hypomethy-
lation and re-expression of p15INK4b, a tumor suppressor gene, in
human acute myeloid leukemia (AML) cells by targeting Dnmt 1, 3a,
and 3b (Garzon et al., 2009). Therefore, co-expression of miR-29b and
reprogramming factors is expected to induce complete reprogram-
ming of partially reprogrammed cells by promoting demethylation of
promoter regions of pluripotency-associated genes, such as Oct4 and
Nanog. It will be interesting to compare the effects of miR-29b and
Dnmt knock-down (or Dnmt inhibitors) on reprogramming.
Recently, two independent studies have demonstrated that
expression of the imprinted Dlk1–Dio3 gene cluster, which codes
for ∼50 conserved miRNAs, is often silenced in iPS cells (Liu et al.,
2010; Stadtfeld et al., 2010). Moreover, treatment of iPS cells with
HDAC inhibitors led to activation of the Dlk1–Dio3 miRNA cluster and
the generation of iPS cells whose developmental potential appears to
be equivalent to that of ES cells (Stadtfeld et al., 2010). These ﬁndings
highlight the importance of achieving the appropriate epigenetic
status of cells during reprogramming, and further reinforce the critical
roles played by miRNAs in the establishment and maintenance of
pluripotency. Investigating the effects of exogenous expression ofindividual miRNAs encoded by the Dlk1–Dio3 cluster during repro-
gramming will provide further insight into the speciﬁc roles of this
miRNA cluster.
miRNAs as modulators of pluripotency-promoting signaling
pathways during reprogramming
Signaling pathways involved in regulation of a multitude of
cellular functions play essential roles in relaying external cues to
cells. Among the different pluripotency-sustaining signaling path-
ways, signiﬁcant progress has been made towards understanding the
roles of TGF-β/Activin signaling in human ES cells (Xu et al., 2008;
Vallier et al., 2009). Inhibition of TGF-β/Activin signaling using a
chemical inhibitor induces human ES cells to differentiate (James
et al., 2005). TGF-β signaling is activated when Activin binds to the
ALK4 receptor leading to phosphorylation of SMAD 2/3. Phosphory-
lated SMAD 2/3 binds to SMAD4 and the resulting complex associates
with the promoters of its target genes to activate their expression (Xu
et al., 2008). Recent work has shown that SMAD 2/3 complex binds to
SMAD binding elements (SBE) in the Nanog promoter and activates its
expression in human ES cells (Xu et al., 2008; Vallier et al., 2009).
miRNAs that inhibit TGF-β signaling have been identiﬁed in
different cell types. In mouse liver stem cells, miR-23b and miR-24-1
inhibit TGF-β signaling by downregulating SMAD3 (Rogler et al.,
2009). In human haematopoietic progenitor cells, miR-24-1 inhibits
TGF-β/Activin signaling by targeting the ALK4 receptor (Wang et al.,
2008a). miR-21 induces adipogenic differentiation of human adipose
tissue derived mesenchymal stem cells by downregulating the
expression of the type II TGF-β receptor (Kim et al., 2009d).
Additionally, miRNA proﬁling experiments have shown that miR-
24-1, miR-23b, and miR-21 are expressed at high levels in human
IMR90 ﬁbroblasts, whereas their expression is signiﬁcantly lower in
human ES cells and iPS cells generated from IMR90 ﬁbroblasts
(Wilson et al., 2009). This suggests that inhibiting the activity of miR-
24-1, miR-23b, and miR-21 may promote reprogramming of human
somatic cells into human iPS cells by activating TGF-β/Activin
signaling. Apart from its role in regulating TGF-β signaling, miR-24-
1 also inhibits cell proliferation by targeting important cell cycle
regulators, such as c-Myc, and E2F2 (Lal et al., 2009). By inhibiting the
activity of miR-24-1, it may be possible to generate iPS cells without c-
Myc and Klf4. In this regard, c-Myc and Klf4 appear to promote
reprogramming, at least in part, by increasing cellular proliferation
(Yamanaka., 2007). Apart from the miRNAs discussed above, it will be
important to identify and studymiRNAs thatmodulate other signaling
pathways, such as Wnt and Mek/Erk, in the process of reprogram-
ming. Again, it is important to recognize that different signaling
pathways control the self-renewal and pluripotency of human and
mouse ES cells (Yu and Thomson, 2008).
c-Myc induced miRNAs and miRNAs involved in regulation of ES
cell self-renewal and cell cycle progression as promoters
of reprogramming
As mentioned earlier, c-Myc-regulated miRNAs, miR-141, miR-
200, and miR-429, have been shown to attenuate differentiation of
mouse ES cells upon LIF withdrawal (Lin et al., 2009). Additionally, the
pro-tumorigenic miR-17-92 cluster, which is transcriptionally acti-
vated by c-Myc in tumor cell models, is enriched in both human ES
cells and human iPS cells (O'Donnell et al., 2005; Wilson et al., 2009).
Hence, it would be interesting to determine whether these c-Myc-
regulated miRNAs exert positive effects on somatic cell reprogram-
ming. Similarly, miR-92b and miRNAs belonging to the miR-520
cluster should be tested for their effects on reprogramming given their
established or predicted roles in promoting ES cell proliferation (Ren
et al., 2009; Sengupta et al., 2009). In addition, inhibitors of miR-134,
miR-296 and miR-470 miRNAs appear to be good candidates for
23S.K. Mallanna, A. Rizzino / Developmental Biology 344 (2010) 16–25inﬂuencing reprogramming, given that these miRNAs have been
shown to interfere with the self-renewal of ES cells (Tay et al., 2008a).
Finally, various miRNA mimics and miRNA inhibitors, when used
in the optimal combination with one another, are expected to
improve both the efﬁciency of producing iPS cells and the quality of
the iPS cells produced. Interestingly, it has been reported that
reprogramming of tumor cells can be achieved using only miRNAs,
speciﬁcally by exogenous expression of the miR-302 cluster (Lin et al.,
2008). Furthermore, it was claimed that the miR-302 cluster can also
reprogram primary cultured somatic cells, but no data was presented
(Lin et al., 2008). Thus, the potential clinical use of human iPS cells
generated solely with miRNAs remains to be determined. Further-
more, the effectiveness of miRNA-based reprogramming strategies
may be cell-type dependent. From an experimental standpoint, it
would be interesting to test the ability of the miRNAs, including the
miR-302 cluster, to reprogram neural stem cells, which only require
Oct4 for reprogramming (Kim et al., 2009a; Kim et al., 2009b).
Conclusion
Research over the past decade has contributed substantially towards
understanding themolecularmechanisms that control self-renewal and
pluripotency of ES cells. The identiﬁcation of miRNAs and their varied
effects on ES cells has provided a far better understanding of the
molecular mechanisms that ﬁne tune the complex gene regulatory
networks which control the proliferation and the differentiation of
pluripotent stem cells. SpeciﬁcmiRNAs, both ES cell- and tissue-speciﬁc,
have been shown to regulate the expression of critical transcription
factors, cell cycle proteins, epigenetic modiﬁers, and other regulatory
proteins, to confer either ES cell or differentiated cell phenotypes.
Notwithstanding the immense progress made recently towards
understanding the contribution of miRNAs in maintaining the plurip-
otent state, much remains to be done. Recent work by several groups
have demonstrated that iPS cells and ES cells can be distinguished by
gene expression signatures, including expression ofmiRNAs (Chin et al.,
2009; Liu et al., 2010; Stadtfeld et al., 2010). These ﬁndings suggest that
iPS cells are very similar to ES cells, but there are important differences
between them. Finally, as discussed in this review, our understanding of
the roles of miRNAs in somatic cell reprogramming is relatively limited.
Therefore, future studies that modulate the expression of speciﬁc
miRNAs during the generation of iPS cells are expected to both improve
reprogramming itself and provide greater insights into the mechanistic
details surrounding the generation of iPS cells. Equally important,
extensive characterization of the miRNA status of human iPS cells is
likely to have signiﬁcant impact on the potential clinical use of these
cells in cell-based therapies.
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